Published in J Immunol on December 15, 1990
Complement and systemic lupus erythematosus. Arthritis Res (2002) 1.58
Polymorphism of the complement receptor 1 gene correlates with the hematologic response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. Haematologica (2013) 1.04
Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1. Blood (2008) 0.94
Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol Med (2008) 0.93
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases. Gut (2002) 0.83
Complement-independent binding of microorganisms to primate erythrocytes in vitro by cross-linked monoclonal antibodies via complement receptor 1. Infect Immun (1995) 0.80
Peripheral catabolism of CR1 (the C3b receptor, CD35) on erythrocytes from healthy individuals and patients with systemic lupus erythematosus (SLE). Clin Exp Immunol (1992) 0.80
Autoantibodies against complement receptor 1 (CD35) in SLE, liver cirrhosis and HIV-infected patients. Clin Exp Immunol (2003) 0.76
CR1 exon variants are associated with lowered CR1 expression and increased susceptibility to SLE in a Plasmodium falciparum endemic population. Lupus Sci Med (2016) 0.75
High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment. J Vis Exp (2017) 0.75
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med (1995) 5.50
Primate erythrocyte-immune complex-clearing mechanism. J Clin Invest (1983) 3.57
Thiazide diuretic monotherapy for hypertension: diuretic's dark side just got darker. Kidney Int (2007) 2.84
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int (2001) 2.17
A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis. North America Nephrotic Syndrome Study Group. Kidney Int (1999) 1.82
Studies of the mechanism by which phosphate infusion lowers serum calcium concentration. J Clin Invest (1966) 1.81
The living donor in kidney transplantation. Ann Intern Med (1987) 1.81
Interaction of rifampin and glucocorticoids. Adverse effect on renal allograft function. JAMA (1976) 1.77
Serum C3 levels are diagnostically more sensitive and specific for systemic lupus erythematosus activity than are serum C4 levels. The Lupus Nephritis Collaborative Study Group. Am J Kidney Dis (1991) 1.66
Complement depletion accelerates the clearance of immune complexes from the circulation of primates. J Clin Invest (1984) 1.46
Renoprotective therapy: how good can it get? Kidney Int (2000) 1.39
Therapy of membranous nephropathy: what to do after the after (meta) analyses. J Am Soc Nephrol (1995) 1.39
CR1 and CR1-like: the primate immune adherence receptors. Immunol Rev (2001) 1.27
Molecular identification of Knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood (2001) 1.25
The complex nature of serum C3 and C4 as biomarkers of lupus renal flare. Lupus (2010) 1.21
Spot urine protein/creatinine ratios are unreliable estimates of 24 h proteinuria in most systemic lupus erythematosus nephritis flares. Kidney Int (2007) 1.18
Renal artery dissection causing renal infarction in otherwise healthy men. Am J Kidney Dis (1997) 1.17
Differential binding of immunoglobulin A and immunoglobulin G1 immune complexes to primate erythrocytes in vivo. Immunoglobulin A immune complexes bind less well to erythrocytes and are preferentially deposited in glomeruli. J Clin Invest (1986) 1.11
5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol (2012) 1.10
The erythrocyte-immune complex-glomerulonephritis connection in man. Kidney Int (1987) 1.07
Some hemodynamic determinants of immune complex trapping by the kidney. Kidney Int (1978) 1.05
Clearance of human antibody/DNA immune complexes and free DNA from the circulation of the nonhuman primate. Clin Immunol Immunopathol (1987) 1.04
Phenotypes, genotypes and disease susceptibility associated with gene copy number variations: complement C4 CNVs in European American healthy subjects and those with systemic lupus erythematosus. Cytogenet Genome Res (2009) 1.03
Complement activation induces the expression of decay-accelerating factor on human mesangial cells. J Immunol (1991) 1.02
Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Am J Kidney Dis (1999) 1.02
Cytomegalovirus inhibits major histocompatibility class II expression on infected endothelial cells. Am J Pathol (1994) 1.01
The effect of sodium hydroxide and hydrochloric acid on human epidermis. An electronmicroscopic study. Acta Derm Venereol (1972) 1.01
Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion (2004) 0.99
Diagnostic significance of hypocomplementemia. Kidney Int (1991) 0.97
Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes. J Immunol (1987) 0.97
Measurement of the fractional uptake of macromolecules by the renal vascular bed compared to other vascular beds. J Lab Clin Med (1976) 0.97
Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol (1999) 0.93
Consumption of erythrocyte CR1 (CD35) is associated with protection against systemic lupus erythematosus renal flare. Clin Exp Immunol (2006) 0.92
Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q. Lupus (2011) 0.92
Subacute bacterial endocarditis masquerading as type III essential mixed cryoglobulinemia. J Am Soc Nephrol (1997) 0.91
Factors influencing the binding of large immune complexes to the primate erythrocyte CR1 receptor. Clin Immunol Immunopathol (1984) 0.90
Measurement of SC5b-9 in urine in patients with the nephrotic syndrome. Kidney Int (1991) 0.90
Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans. Lupus (2012) 0.85
Immune complexes bind preferentially to specific subpopulations of human erythrocytes. Clin Immunol Immunopathol (1990) 0.85
Immune complex erythrocyte complement receptor interactions in vivo during induction of glomerulonephritis in nonhuman primates. J Lab Clin Med (1990) 0.84
Reversal of chronic end-stage renal failure due to myeloma kidney. Ann Intern Med (1979) 0.83
Primary sequence of an alternatively spliced form of CR1. Candidate for the 75,000 M(r) complement receptor expressed on chimpanzee erythrocytes. J Immunol (1994) 0.83
Of mice and men: the relevance of the mouse to the study of human SLE. Immunol Res (2001) 0.83
Rapidly progressive glomerulonephritis superimposed on diabetic glomerulosclerosis. Recognition and treatment. JAMA (1982) 0.82
Lentigo maligna of the fingertip. Clinical, histologic, and ultrastructural studies of two cases. Arch Dermatol (1973) 0.82
Renal subcapsular pressure--a new intrarenal pressure measurement. Am J Physiol (1971) 0.82
The baboon erythrocyte complement receptor is a glycophosphatidylinositol-linked protein encoded by a homologue of the human CR1-like genetic element. J Immunol (1996) 0.82
The chimpanzee and cynomolgus monkey erythrocyte immune adherence receptors are encoded by CR1-like genes. Immunogenetics (2000) 0.82
Experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int (1991) 0.81
The role of the complement system in renal injury. Semin Nephrol (1992) 0.81
Biologic significance of the erythrocyte complement receptor: a primate perquisite. J Lab Clin Med (1991) 0.81
Stimulating erythropoiesis increases complement receptor expression on primate erythrocytes. Clin Immunol Immunopathol (1992) 0.80
Effect of enalapril therapy on glomerular accumulation of immune complexes and mesangial matrix in experimental glomerulonephritis in the nonhuman primate. Am J Kidney Dis (1997) 0.80
Venereal warts vs Bowen disease. A histologic and ultrastructural study of five cases. JAMA (1977) 0.80
Renal artery pressure gradients in patients with angiographic evidence of atherosclerotic renal artery stenosis. Am J Kidney Dis (1994) 0.80
Effect of renal decapsulation on renal function. Am J Physiol (1975) 0.80
Erythropoietin therapy in humans increases erythrocyte expression of complement receptor type 1 (CD35). J Am Soc Nephrol (1994) 0.80
Stability of renal transplant function with alternate-day corticosteroid therapy. JAMA (1980) 0.79
Renal expansion in saline loading. Am J Physiol (1974) 0.78
Simple method for monitoring 24-hour urinary urea nitrogen excretion. J Lab Clin Med (1986) 0.78
A comparison of taste acuity for salt in renal patients vs. normal subjects. J Am Diet Assoc (1987) 0.78
Renal autotransplantation in the loin pain-hematuria syndrome: a cautionary note. Am J Kidney Dis (1992) 0.78
An electron microscopic study of human epidermis after acetone and kerosene administration. J Invest Dermatol (1973) 0.78
Adverse effect of exercise on immune complex-mediated glomerulonephritis. Nephron (1985) 0.78
Platelet inhibitors in human renal homotransplantation: randomized comparison of aspirin versus dipyridamole. Transplant Proc (1980) 0.77
Primary hypothyroidism in chronic renal failure. Clin Nephrol (1986) 0.77
Nodular primary localized cutaneous amyloidosis. Arch Dermatol (1977) 0.76
Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells. Kidney Int (1994) 0.76
Whole kidney volume/pressure relationships. Kidney Int (1975) 0.76
Plasmapheresis in the treatment of renal allograft rejection. Proc Clin Dial Transplant Forum (1979) 0.76
Preliminary clinical experience with the titanium Greenfield vena caval filter. Arch Surg (1989) 0.76
Effect of chronic human recombinant erythropoietin therapy on antibody responses to immunization in chronic hemodialysis patients. Kidney Int (1996) 0.76
Human erythrocytes inhibit complement-mediated solubilization of immune complexes. J Immunol (1989) 0.76
Shortcomings of physical examination and impedance plethysmography in the diagnosis of lower extremity deep venous thrombosis. Angiology (1987) 0.76
Rate of antigen entry into the circulation in experimental versus naturally occurring immune complex glomerulonephritis. J Am Soc Nephrol (1994) 0.75
Management of urinary tract infections. N Engl J Med (1994) 0.75
Operative risks: the clinical evaluation and management of disorders of water and electrolyte balance. Clin Obstet Gynecol (1973) 0.75
Metacarpophalangeal joint replacement. Case report of 20-year follow-up. Phys Ther (1979) 0.75
Angiotensin as a possible intrarenal hormone in isolated dog kidneys. Circ Res (1973) 0.75
Infantile polycystic kidney disease in the adult. Arch Intern Med (1977) 0.75
Effect of glucocorticoids on WBC counts in splenectomized renal transplant recipients. Arch Intern Med (1978) 0.75
Effect of expansion of renal parenchymal volume on renal function. Nephron (1978) 0.75
Platelet involvement in experimental immune complex-mediated glomerulonephritis in the nonhuman primate. Kidney Int (1993) 0.75